Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China
· Delayed Price · Currency is CNY 12.17
+0.16 (1.33%)
Mar 10, 2026, 3:00 PM CST
SHA:603998 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 5,344 | 4,576 | 4,819 | 3,521 | 2,920 | 2,572 | Upgrade
|
| Market Cap Growth | 25.58% | -5.06% | 36.87% | 20.58% | 13.52% | -28.67% | Upgrade
|
| Enterprise Value | 5,737 | 5,188 | 5,463 | 3,898 | 3,469 | 2,836 | Upgrade
|
| Last Close Price | 12.17 | 9.90 | 10.18 | 7.23 | 5.90 | 5.15 | Upgrade
|
| PE Ratio | 18.16 | 17.93 | 25.80 | 12.32 | 41.69 | 40.32 | Upgrade
|
| Forward PE | 17.51 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | Upgrade
|
| PS Ratio | 3.18 | 2.57 | 2.96 | 1.97 | 1.86 | 2.01 | Upgrade
|
| PB Ratio | 3.05 | 2.64 | 3.03 | 2.34 | 2.24 | 2.03 | Upgrade
|
| P/TBV Ratio | 4.65 | 4.27 | 5.26 | 4.05 | 5.15 | 3.82 | Upgrade
|
| P/FCF Ratio | 23.86 | 45.69 | - | 27.01 | 3188.95 | 37.33 | Upgrade
|
| P/OCF Ratio | 17.65 | 23.47 | 55.06 | 11.67 | 15.73 | 10.87 | Upgrade
|
| EV/Sales Ratio | 3.41 | 2.92 | 3.35 | 2.17 | 2.21 | 2.22 | Upgrade
|
| EV/EBITDA Ratio | 15.76 | 16.20 | 23.24 | 17.43 | 18.18 | 17.46 | Upgrade
|
| EV/EBIT Ratio | 19.98 | 20.99 | 33.45 | 25.31 | 28.12 | 30.84 | Upgrade
|
| EV/FCF Ratio | 25.61 | 51.80 | - | 29.90 | 3788.09 | 41.16 | Upgrade
|
| Debt / Equity Ratio | 0.30 | 0.40 | 0.43 | 0.39 | 0.42 | 0.35 | Upgrade
|
| Debt / EBITDA Ratio | 1.46 | 2.17 | 2.87 | 2.56 | 2.74 | 2.73 | Upgrade
|
| Debt / FCF Ratio | 2.38 | 7.00 | - | 4.56 | 602.87 | 6.43 | Upgrade
|
| Net Debt / Equity Ratio | 0.18 | 0.23 | 0.28 | 0.10 | 0.21 | 0.10 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.87 | 1.23 | 1.93 | 0.69 | 1.46 | 0.76 | Upgrade
|
| Net Debt / FCF Ratio | 1.40 | 3.92 | -3.45 | 1.18 | 303.32 | 1.79 | Upgrade
|
| Asset Turnover | 0.53 | 0.56 | 0.54 | 0.64 | 0.63 | 0.60 | Upgrade
|
| Inventory Turnover | 1.38 | 1.47 | 1.65 | 2.10 | 2.43 | 2.25 | Upgrade
|
| Quick Ratio | 0.47 | 0.49 | 0.38 | 0.80 | 0.45 | 0.62 | Upgrade
|
| Current Ratio | 0.86 | 0.88 | 0.74 | 1.19 | 0.69 | 0.91 | Upgrade
|
| Return on Equity (ROE) | 16.62% | 15.04% | 11.60% | 19.68% | 5.44% | 4.36% | Upgrade
|
| Return on Assets (ROA) | 5.68% | 4.87% | 3.40% | 3.42% | 3.12% | 2.71% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.81% | 10.36% | 7.79% | 8.04% | 6.40% | 5.28% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.30% | 12.60% | 8.90% | 8.00% | 8.50% | 6.70% | Upgrade
|
| Earnings Yield | 5.53% | 5.58% | 3.88% | 8.12% | 2.40% | 2.48% | Upgrade
|
| FCF Yield | 4.19% | 2.19% | -2.72% | 3.70% | 0.03% | 2.68% | Upgrade
|
| Dividend Yield | 2.08% | 2.53% | 2.85% | 4.84% | 2.54% | 2.33% | Upgrade
|
| Payout Ratio | 73.33% | 50.74% | 93.36% | 43.27% | 66.85% | 107.45% | Upgrade
|
| Buyback Yield / Dilution | 2.28% | 1.08% | -2.70% | 1.06% | -2.93% | 2.99% | Upgrade
|
| Total Shareholder Return | 4.36% | 3.60% | 0.15% | 5.90% | -0.39% | 5.32% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.